Deutsche Bank’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,843
| Closed | -$11K | – | 5041 |
|
|
2019
Q2 | $11K | Sell |
1,843
-6,718
| -78% | -$40.1K | ﹤0.01% | 4582 |
|
|
2019
Q1 | $29K | Sell |
8,561
-141,764
| -94% | -$480K | ﹤0.01% | 4449 |
|
|
2018
Q4 | $595K | Buy |
150,325
+134,560
| +854% | +$533K | ﹤0.01% | 3178 |
|
|
2018
Q3 | $311K | Buy |
15,765
+7,808
| +98% | +$154K | ﹤0.01% | 3955 |
|
|
2018
Q2 | $253K | Sell |
7,957
-4,437
| -36% | -$141K | ﹤0.01% | 4075 |
|
|
2018
Q1 | $458K | Sell |
12,394
-6,156
| -33% | -$227K | ﹤0.01% | 3695 |
|
|
2017
Q4 | $1.46M | Buy |
+18,550
| New | +$1.46M | ﹤0.01% | 2913 |
|